A detailed history of Deutsche Bank Ag\ transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 4,843,692 shares of ORGO stock, worth $19.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,843,692
Previous 2,504,059 93.43%
Holding current value
$19.6 Million
Previous $7.01 Million 97.58%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.42 - $3.24 $5.66 Million - $7.58 Million
2,339,633 Added 93.43%
4,843,692 $13.9 Million
Q2 2024

Aug 14, 2024

SELL
$2.28 - $3.03 $14,012 - $18,622
-6,146 Reduced 0.24%
2,504,059 $7.01 Million
Q1 2024

May 15, 2024

SELL
$2.61 - $4.49 $3,186 - $5,482
-1,221 Reduced 0.05%
2,510,205 $7.13 Million
Q4 2023

Feb 14, 2024

BUY
$1.97 - $4.21 $4.87 Million - $10.4 Million
2,474,444 Added 6690.94%
2,511,426 $10.3 Million
Q3 2023

Nov 09, 2023

SELL
$2.34 - $4.43 $736,589 - $1.39 Million
-314,782 Reduced 89.49%
36,982 $117,000
Q2 2023

Aug 14, 2023

SELL
$1.9 - $4.3 $33,719 - $76,312
-17,747 Reduced 4.8%
351,764 $1.17 Million
Q1 2023

May 15, 2023

BUY
$1.89 - $2.93 $3,713 - $5,757
1,965 Added 0.53%
369,511 $787,000
Q4 2022

Feb 13, 2023

BUY
$2.48 - $3.43 $33,561 - $46,418
13,533 Added 3.82%
367,546 $988,000
Q3 2022

Nov 14, 2022

SELL
$3.14 - $6.43 $32,455 - $66,460
-10,336 Reduced 2.84%
354,013 $1.15 Million
Q2 2022

Aug 11, 2022

SELL
$4.74 - $8.15 $7,105 - $12,216
-1,499 Reduced 0.41%
364,349 $1.78 Million
Q1 2022

May 13, 2022

SELL
$6.47 - $9.57 $170,956 - $252,868
-26,423 Reduced 6.74%
365,848 $2.79 Million
Q4 2021

Feb 11, 2022

SELL
$9.02 - $13.5 $104,595 - $156,546
-11,596 Reduced 2.87%
392,271 $3.63 Million
Q3 2021

Nov 04, 2021

SELL
$13.71 - $17.18 $578,959 - $725,494
-42,229 Reduced 9.47%
403,867 $5.75 Million
Q2 2021

Aug 11, 2021

BUY
$14.92 - $23.23 $5.76 Million - $8.97 Million
386,008 Added 642.4%
446,096 $7.41 Million
Q1 2021

May 13, 2021

BUY
$7.33 - $21.06 $301,966 - $867,587
41,196 Added 218.06%
60,088 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $27,373 - $56,783
7,541 Added 66.43%
18,892 $142,000
Q3 2020

Nov 12, 2020

BUY
$3.29 - $4.58 $3,237 - $4,506
984 Added 9.49%
11,351 $44,000
Q2 2020

Aug 13, 2020

BUY
$2.86 - $4.61 $19,096 - $30,780
6,677 Added 180.95%
10,367 $40,000
Q1 2020

May 14, 2020

SELL
$2.92 - $5.31 $648 - $1,178
-222 Reduced 5.67%
3,690 $12,000
Q4 2019

Feb 14, 2020

BUY
$4.7 - $8.11 $4,201 - $7,250
894 Added 29.62%
3,912 $18,000
Q3 2019

Nov 14, 2019

SELL
$3.57 - $8.09 $7,554 - $17,118
-2,116 Reduced 41.22%
3,018 $18,000
Q2 2019

Aug 14, 2019

SELL
$6.58 - $8.69 $64,859 - $85,657
-9,857 Reduced 65.75%
5,134 $39,000
Q1 2019

May 15, 2019

BUY
$7.05 - $150.0 $105,686 - $2.25 Million
14,991 New
14,991 $112,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $530M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.